Max Masucci
Stock Analyst at Roth MKM
(4.07)
# 1,690
Out of 4,988 analysts
165
Total ratings
44%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Max Masucci
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASS 908 Devices | Reiterated: Buy | $11 → $13 | $10.53 | +23.46% | 3 | Aug 12, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $32 | $29.20 | +9.59% | 9 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | $8 | $7.79 | +2.70% | 5 | Aug 6, 2026 | |
| XGN Exagen | Reiterated: Buy | $8 → $9 | $8.41 | +7.02% | 5 | Aug 5, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $40 | $35.34 | +13.19% | 20 | Jul 31, 2026 | |
| BLFS BioLife Solutions | Reiterated: Buy | $29 → $25 | $36.69 | n/a | 5 | Aug 9, 2023 | |
| BRKR Bruker | Reiterated: Hold | $75 → $79 | $61.39 | n/a | 4 | Aug 4, 2023 | |
| RVTY Revvity | Reiterated: Buy | $155 → $151 | $143.45 | n/a | 5 | Aug 2, 2023 | |
| GH Guardant Health | Reiterated: Buy | $70 → $53 | $179.38 | n/a | 18 | Feb 24, 2023 | |
| CTKB Cytek Biosciences | Reiterated: Buy | $17 | $5.30 | n/a | 2 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $99 | $101.10 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $15 | $3.07 | n/a | 24 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.40 | n/a | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.24 | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.19 | n/a | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $100 | $369.39 | n/a | 22 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $1.60 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $39 | $1.36 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.966 | n/a | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.65 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.12 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 → $515 | $239.62 | n/a | 16 | Jul 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $0.0006 | n/a | 11 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.25 | $0.01 | n/a | 1 | Apr 2, 2020 |
908 Devices
Aug 12, 2026
Reiterated: Buy
Price Target: $11 → $13
Current: $10.53
Upside: +23.46%
Biodesix
Aug 6, 2026
Reiterated: Buy
Price Target: $32
Current: $29.20
Upside: +9.59%
Alpha Teknova
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $7.79
Upside: +2.70%
Exagen
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $8.41
Upside: +7.02%
Castle Biosciences
Jul 31, 2026
Reiterated: Buy
Price Target: $40
Current: $35.34
Upside: +13.19%
BioLife Solutions
Aug 9, 2023
Reiterated: Buy
Price Target: $29 → $25
Current: $36.69
Upside: n/a
Bruker
Aug 4, 2023
Reiterated: Hold
Price Target: $75 → $79
Current: $61.39
Upside: n/a
Revvity
Aug 2, 2023
Reiterated: Buy
Price Target: $155 → $151
Current: $143.45
Upside: n/a
Guardant Health
Feb 24, 2023
Reiterated: Buy
Price Target: $70 → $53
Current: $179.38
Upside: n/a
Cytek Biosciences
Dec 13, 2022
Reiterated: Buy
Price Target: $17
Current: $5.30
Upside: n/a
Nov 15, 2022
Reiterated: Buy
Price Target: $5 → $99
Current: $101.10
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $18 → $15
Current: $3.07
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $16.40
Upside: n/a
Sep 8, 2022
Reiterated: Buy
Price Target: n/a
Current: $14.24
Upside: n/a
Jun 23, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.19
Upside: n/a
May 6, 2022
Reiterated: Buy
Price Target: $110 → $100
Current: $369.39
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $1.60
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $32 → $39
Current: $1.36
Upside: n/a
Nov 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $0.966
Upside: n/a
Oct 14, 2021
Reiterated: Hold
Price Target: n/a
Current: $9.65
Upside: n/a
Oct 14, 2021
Reiterated: Buy
Price Target: n/a
Current: $1.12
Upside: n/a
Jul 14, 2021
Reiterated: Buy
Price Target: $470 → $515
Current: $239.62
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $3.5
Current: $0.0006
Upside: n/a
Apr 2, 2020
Initiated Coverage: Buy
Price Target: $0.25
Current: $0.01
Upside: n/a